Folyóiratcikkek tallózása szerző szerint "Lakatos, Péter László"

1-20 / 96

Következő oldal

Access to biologicals in Crohn's disease in ten European countries

Péntek, Márta; Lakatos, Péter László; Oorsprong, T; Gulácsi, László; Pavlova, M; Groot, W; Rencz, F; Brodszky, Valentin; Baji, Petra; Crohn’s Disease Research Group (2017)

AIM To analyze access (availability, affordability and acceptability) to biologicals for Crohn's disease (CD) in ten European countries and to explore the associations between these dimensions, the uptake of biologicals ...
Adalimumab monotherapy versus combination therapy with immunomodulators in patients with Crohn’s disease: a systematic review and meta-analysis

Kopylov, U; Al-Taweel, T; Yaghoobi, M; Nauche, B; Bitton, A; Lakatos, Péter László; Ben-Horin, S; Afif, W; Seidman, EG (2014)
A felső és alsó endoszkópiák indikációja, a diagnózisok megoszlása és minőségi mutatók 2010–2011-ben a Semmelweis Egyetem I. Belgyógyászati Klinikáján

Gönczi, Lóránt; Kürti, Zsuzsanna; Golovics, Petra Anna; Végh, Zsuzsanna; Lovász, Barbara Dorottya; Dorkó A; Seres A; Sümegi L; Menyhárt O; Kiss, Lajos Sándor; Papp J; Gecse K; Lakatos, Péter László (2016)
Antibody and cell-mediated immune response to whole virion and split virion influenza vaccine in patients with inflammatory bowel disease on maintenance immunosuppressive and biological therapy

Bálint, Anita; Farkas, Klaudia; Pallagi, Éva; Terhes, Gabriella; Zsoldiné Urbán, Edit; Szűcs, M; Nyári, Tibor András; Csörgő Sándorné, Bata Zsuzsanna; Nagy, Ferenc; Szepes, Zoltán; Miheller, Pál; Lőrinczy, Katalin; Lakatos, Péter László; Lovász, Barbara Dorottya; Szamosi, T; Kulcsár, A; Berényi, A; Törőcsik, D; Daróczi, T; Saródi, Z; Wittmann, Tibor; Molnár, Tamás (2015)
Antigenic response to CT‐P13 and infliximab originator in inflammatory bowel disease patients shows similar epitope recognition

Goncalves, J; Santos, M; Acurcio, R; Iria, I; Gouveia, L; Brito, P; Cunha-Santos, A; Aires, da Silva F; Alcobia, A; Delgado, Alves J; Carey, J; Doerner, T; Eurico, Fonseca J; Palmela, C; Lima, Vieira C; Fiorino, G; Strik, A; Yavzori, M; Rosa, I; Correia, L; Magro, F; D'Haens, G; Ben-Horin, S; Lakatos, Péter László; Danese, S (2018)
A review of mortality and surgery in ulcerative colitis: milestones of the seriousness of the disease

Bernstein, CN; Ng, SC; Lakatos, Péter László; Moum, B; Loftus, EV Jr; the, Epidemiology and Natural History Task Force of the International Organization of the Study of Inflammatory Bowel Disease (2013)
Association of extraintestinal manifestations and anaemia with disease outcomes in patients with inflammatory bowel disease

Végh, Zsuzsanna; Kürti, Zsuzsanna; Gönczi, Lóránt; Golovics, Petra Anna; Lovász, Barbara Dorottya; Szita, I; Balogh, M; Pandur, T; Vavricka, SR; Rogler, G; Lakatos, L; Lakatos, Péter László (2016)
A székletkalprotektin meghatározásának szerepe a bélbetegségek diagnosztikájában és kezelésében

Iliás, Ákos; Rózsa Fióna Petra; Gönczi, Lóránt; Lovász, Barbara Dorottya; Kürti, Zsuzsanna; Lakatos, Péter László (2019)
Baseline characteristics and disease phenotype in inflammatory bowel disease results of a paediatric IBD cohort

Müller, Katalin Eszter; Lakatos, Péter László; Kovacs JB; Arató, András; Herczegné Várkonyi, Ágnes; Nemes, Éva; Tárnok, András; Tóth, Gergely Péter; Papp, Mária; Solyom E; Horvath A; Guthy I; Kovacs M; Hungarian IBD Registry Group (HUPIR); Veres, Gábor (2016)

OBJECTIVES: Predicting short-term relapses and long-term prognosis is of utmost importance in paediatric inflammatory bowel disease (IBD). Our aim was to investigate the short-term disease outcome and medication during ...
Biohasonlók a gasztroenterológiában: táguló horizont

Gecse, Krisztina; Lakatos, Péter László (2014)
Biological therapy in inflammatory bowel diseases: access in Central and Eastern Europe

Rencz, Fanni; Péntek, Márta; Bortlik, M; Zagorowicz, E; Hlavaty, T; Śliwczyński, A; Diculescu, MM; Kupcinskas, L; Gecse, Krisztina; Gulácsi, László; Lakatos, Péter László (2015)
Biosimilar monoclonal antibodies for inflammatory bowel disease: Current comfort & future prospects

Gecse, Krsztina; Lakatos, Péter László (2016)
Biosimilars in Inflammatory Bowel Disease: Facts and Fears of Extrapolation

Ben-Horin, S; Casteele, NV; Schreiber, S; Lakatos, Péter László (2016)
Biosimilars in ulcerative colitis: When and for who?

Iliás, Ákos; Gönczi, Lóránt; Kürti, Zsuzsanna; Lakatos, Péter László (2018)

The introduction of biological agents has revolutionized the management of ulcerative colitis (UC). Biosimilars are considered to be equivalent to the reference biologic products in terms of pharmacokinetic properties, ...
Burden of Clostridium difficile infection between 2010 and 2013: trends and outcomes from an academic center in Eastern Europe

Kürti, Zsuzsanna; Lovász, Barbara Dorottya; Mandel MD; Csima, Zoltán; Golovics, Petra Anna; Csako BD; Mohas A; Gönczi, Lóránt; Gecse, Krisztina; Kiss, Lajos Sándor; Szathmári, Miklós; Lakatos, Péter László (2015)
Comparative effectiveness of infliximab versus adalimumab in patients with biological naïve Crohn’s Disease

Benmassaoud A; Al-Taweel T; Sasson MS; Moza D; Strohl M; Kopylov U; Paradis-Suprenant L; Almaimani M; Bitton A Afif W; Lakatos, Péter László; Bessissow T (2018)

Direct head-to-head studies comparing the long-term outcomes of infliximab (IFX) to adalimumab (ADA) in Crohn's disease (CD) are sparse.
Comparison of the effects of 1,25 dihydroxyvitamin D and 25 hydroxyvitamin D on bone pathology and disease activity in Crohn's disease patients

Miheller, Pál; Műzes, Györgyi; Hritz, István; Lakatos G,; Pregun, István; Lakatos, Péter László; Herszényi, László; Tulassay, Zsolt (2009)
Cost-effectiveness of biological treatment sequences for fistulising Crohn’s disease across Europe

Baji, Petra; Gulácsi, László; Brodszky, Valentin; Végh, Zsuzsanna; Danese, S; Irving, PM; Peyrin, Biroulet L; Schreiber, S; Rencz, Fanni; Lakatos, Péter László; Péntek, Márta (2018)

Background: In clinical practice, treatment sequences of biologicals are applied for active fistulising Crohn's disease, however underlying health economic analyses are lacking.
Decreasing trends in hospitalizations during anti-TNF therapy are associated with time to anti-TNF therapy: results from two referral centers

Mandel, MD; Bálint, Anita; Golovics, Petra Anna; Végh, Zsuzsanna; Mohas, A; Szilágyi, Blanka Krisztina; Szabo, A; Kürti, Zsuzsanna; Kiss, Lajos Sándor; Lovász, Barbara Dorottya; Gecse, Krisztina; Farkas, Klaudia; Molnár, Tamás; Lakatos, Péter László (2014)
Development of an index to define overall disease severity in IBD

Siegel, CA; Whitman, CB; Spiegel, BM; Feagan, B; Sands, B; Loftus, EV Jr; Panaccione, R; D'Haens, G; Bernstein, CN; Gearry, R; Ng, SC; Mantzaris, GJ; Sartor, B; Silverberg, MS; Riddell, R; Koutroubakis, IE; O'Morain, C; Lakatos, Péter László; McGovern, DP; Halfvarson, J; Reinisch, W; Rogler, G; Kruis, W; Tysk, C; Schreiber, S; Danese, S; Sandborn, W; Griffiths, A; Moum, B; Gasche, C; Pallone, F; Travis, S; Panes, J; Colombel, JF; Hanauer, S; Peyrin-Biroulet, L (2018)

1-20 / 96

Következő oldal

Keresés

Összetett keresés

Tallózás

Teljes repozitórumban
Ebben a gyűjteményben

Hozzáférésem

Bejelentkezés

Folyóiratcikkek tallózása szerző szerint "Lakatos, Péter László"

DSpace/Manakin Repository

Folyóiratcikkek tallózása szerző szerint "Lakatos, Péter László"

Keresés

Tallózás

Teljes repozitórumban

Ebben a gyűjteményben

Hozzáférésem